Position in CSTL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,459,776
+$3,119,560 QoQ
Shares Held
145,064
+1727.9% QoQ
Ownership
0.475%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 176 holders
Holding Since
Jun 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CSTL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $1,364,038,790 across 24 Diagnostics & Research names. CSTL ranks #20 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
2,079,578 | $276,230,345 | |
| 2 | ILMN |
Illumina, Inc.
|
907,489 | $159,563,790 | |
| 3 | NEO |
Neogenomics Inc
|
10,113,261 | $147,552,477 | |
| 4 | VCYT |
Veracyte, Inc.
|
2,507,902 | $147,289,084 | |
| 5 | NTRA |
Natera, Inc.
|
511,214 | $138,769,040 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
202,754 | $106,737,815 | |
| 7 | WAT |
Waters Corp /De/
|
272,470 | $102,187,148 | |
| 8 | DGX |
Quest Diagnostics Inc
|
290,970 | $61,671,091 |
All Filings in CSTL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,459,776 | 145,064 | Shares | Sole | 2026-08-11 | |
| 2021-12-31 | $340,216 | 7,936 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,034,008 | 15,549 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $628,364 | 8,569 | Shares | Sole | 2021-10-12 | |
| No filing history on record for this holder in this stock. | ||||||